Literature DB >> 2992675

Impaired phagocytic activity of neutrophils in patients receiving haemodialysis: the critical role of iron overload.

Y Waterlot, B Cantinieaux, C Hariga-Muller, E De Maertelaere-Laurent, J L Vanherweghem, P Fondu.   

Abstract

The metabolic burst (as measured by the spontaneous and stimulated nitroblue tetrazolium tests), the phagocytosis of heat inactivated bakers' yeast and of Staphylococcus aureus, the killing of Staph aureus, and the myeloperoxidase activity of polymorphonuclear neutrophils were studied in 11 patients receiving maintenance haemodialysis. Of these patients, six were polytransfused and had high serum ferritin concentrations (mean 5940 (SD 2925) micrograms/l; group 1), and five had normal serum ferritin values (mean 171 (116) micrograms/l; group 2). Patients in group 1 had a history of more infectious episodes (0.167 v 0.025 per patient per month) and significantly more genitourinary infections (p = 0.015) than those in group 2. Phagocytosis and myeloperoxidase activity were severely reduced in group 1 but normal in group 2. Percentages of neutrophils ingesting one or more particles together with the index of phagocytosis in patients' serum were inversely correlated with serum ferritin concentrations. Four patients in group 1 were treated with desferrioxamine, and after six to 18 weeks of treatment phagocytosis and myeloperoxidase activity had returned to normal in three of them. These data suggest that in patients receiving haemodialysis iron overload due to multiple transfusions plays an important part in the mechanisms underlying the susceptibility to bacterial infections, mediated at least partially through impaired neutrophil function.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2992675      PMCID: PMC1416516          DOI: 10.1136/bmj.291.6494.501

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  18 in total

1.  Iron (II) inactivation of myeloperoxidase.

Authors:  J SCHULTZ; S ROSENTHAL
Journal:  J Biol Chem       Date:  1959-09       Impact factor: 5.157

2.  Neutrophil myeloperoxidase: a simple, reproducible technique to determine activity.

Authors:  M Kitahara; Y Simonian; H J Eyre
Journal:  J Lab Clin Med       Date:  1979-02

Review 3.  The formation of free radicals and the consequences of their reactions in vivo.

Authors:  W A Pryor
Journal:  Photochem Photobiol       Date:  1978 Oct-Nov       Impact factor: 3.421

4.  Fatal granulomatous disease of childhood. An inborn abnormality of phagocytic function.

Authors:  B Holmes; P G Quie; D B Windhorst; R A Good
Journal:  Lancet       Date:  1966-06-04       Impact factor: 79.321

Review 5.  Renal failure and infection.

Authors:  J Z Montgomerie; G M Kalmanson; L B Guze
Journal:  Medicine (Baltimore)       Date:  1968-01       Impact factor: 1.889

6.  Evaluation of iron status in patients on chronic hemodialysis: relative usefulness of bone marrow hemosiderin, serum ferritin, transferrin saturation, mean corpuscular volume and red cell protoporphyrin.

Authors:  J Moreb; M M Popovtzer; M M Friedlaender; A M Konijn; C Hershko
Journal:  Nephron       Date:  1983       Impact factor: 2.847

7.  Host immune status in uremia. IV. Phagocytosis and inflammatory response in vivo.

Authors:  J Nelson; D J Ormrod; T E Miller
Journal:  Kidney Int       Date:  1983-02       Impact factor: 10.612

8.  Deferoxamine enhances phagocytic function of human polymorphonuclear leukocytes.

Authors:  B S van Asbeck; J J Marx; A Struyvenberg; J H van Kats; J Verhoef
Journal:  Blood       Date:  1984-03       Impact factor: 22.113

9.  Non-transferrin plasma iron in beta-thalassaemia/Hb E and haemoglobin H diseases.

Authors:  M Anuwatanakulchai; P Pootrakul; P Thuvasethakul; P Wasi
Journal:  Scand J Haematol       Date:  1984-02

10.  Non-specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity.

Authors:  C Hershko; G Graham; G W Bates; E A Rachmilewitz
Journal:  Br J Haematol       Date:  1978-10       Impact factor: 6.998

View more
  13 in total

1.  Iron sucrose impairs phagocytic function and promotes apoptosis in polymorphonuclear leukocytes.

Authors:  Hirohito Ichii; Yuichi Masuda; Tania Hassanzadeh; Mateen Saffarian; Sastry Gollapudi; Nosratola D Vaziri
Journal:  Am J Nephrol       Date:  2012-06-19       Impact factor: 3.754

Review 2.  Immune cell functions in iron overload.

Authors:  M de Sousa
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

Review 3.  Safety aspects of parenteral iron in patients with end-stage renal disease.

Authors:  G Sunder-Plassmann; W H Hörl
Journal:  Drug Saf       Date:  1997-10       Impact factor: 5.606

Review 4.  Iron supplementation to treat anemia in patients with chronic kidney disease.

Authors:  Anatole Besarab; Daniel W Coyne
Journal:  Nat Rev Nephrol       Date:  2010-10-19       Impact factor: 28.314

Review 5.  Iron and infection in hemodialysis patients.

Authors:  Julie H Ishida; Kirsten L Johansen
Journal:  Semin Dial       Date:  2013-12-12       Impact factor: 3.455

6.  Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies.

Authors:  J R Boelaert; M de Locht; J Van Cutsem; V Kerrels; B Cantinieaux; A Verdonck; H W Van Landuyt; Y J Schneider
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

7.  Iron in granulocytes of nephrotic patients determined by Zeeman electrothermal atomic absorption spectrophotometry.

Authors:  M Matthys; V Blaton; J Spincemaille
Journal:  Biol Trace Elem Res       Date:  1992 Jan-Mar       Impact factor: 3.738

8.  Neutrophils from hereditary hemochromatosis patients are protected from iron excess and are primed.

Authors:  Cyril Renassia; Sabine Louis; Sylvain Cuvellier; Nadia Boussetta; Jean-Christophe Deschemin; Didier Borderie; Karine Bailly; Joel Poupon; Pham My-Chan Dang; Jamel El-Benna; Sandra Manceau; François Lefrère; Sophie Vaulont; Carole Peyssonnaux
Journal:  Blood Adv       Date:  2020-08-25

9.  Evaluation of transferrin-binding protein 2 within the transferrin-binding protein complex as a potential antigen for future meningococcal vaccines.

Authors:  L Lissolo; G Maitre-Wilmotte; P Dumas; M Mignon; B Danve; M J Quentin-Millet
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

10.  Is iron maintenance therapy better than load and hold?

Authors:  Connie M Rhee; Kamyar Kalantar-Zadeh
Journal:  J Am Soc Nephrol       Date:  2013-06-20       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.